Acute Brucella Hepatitis in an Urban Patient

authors:

avatar Mina Asef Zadeh 1 , avatar Abbas Allami ORCID 2 , * , avatar Seyed Moayed Alavian 3

Department of Infectious Diseases, Qazvin University of Medical Sciences, Qazvin, IR.Iran
Department of Infectious Diseases, Qazvin University of Medical Sciences, allami9@yahoo.com, Qazvin, IR.Iran
Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, Tehran, IR.Iran
Hepatitis Monthly: Vol.9, issue 4; 310-313
article type: Case Report
received: March 10, 2009
accepted: May 3, 2009

How To Cite Zadeh M, Allami A, Alavian S. Acute Brucella Hepatitis in an Urban Patient. Hepat Mon. 2009;9(4): 310-313. 

Abstract

A 35-year-old man was referred to our center because of low grade fever, vomiting, yellow sclera, and tenderness in the upper-right quadrant of his abdomen. Laboratory tests showed a white blood cell (WBC) of 7100/µL, a platelet of 184,000/µL, an erythrocyte sedimentation rate (ESR) of 4 mm/h, an alanine aminotransferase (ALT) of 525 U/L, an aspartate aminotransferase AST of 142 U/L, a total bilirubin level of 4.23 mg/dL, and a direct bilirubin level of 3.16 mg/dL. Viral hepatitis markers, immunoglobuline M antibody to cytomegalovirus (anti-CMV IgM), Ebstein-Barr virus (EBV) IgM, and immunologic markers of autoimmune hepatitis were negative. The patient was diagnosed with acute hepatitis. Alkaline phosphatase was in the normal range throughout the course of the disease. Because of the patient's occupation as a butcher and his history of eating semi-cooked sheep testes, serologic tests of brucellosis were conducted; the tests came out positive. We were concerned about the hepatotoxicity of standard regimens; therefore, we started treatment with streptomycin and ciprofloxacin regimens. Although liver enzyme had fallen and fever discontinued, the total and direct bilirubin concentrations in the patient's serum both increased in spite of using 2 weeks of the abovementioned drug regimen. The elevation of bilirubin could have been due to drug hepatotoxicity. Alternatively, a regimen containing ciprofloxacin may have not have been efficient enough and may have had effects on the direct bilirubin concentration. Fortunately, within 8 weeks, progressive recovery was noticed. Brucellosis should be considered in the differential diagnosis of fever and hepatitis for those who live in endemic areas, especially if his/her job was at high risk for acquiring brucellosis. We recommend taking a careful occupational and behavioral history for patients with acute hepatitis syndrome. We assumed that ciprofloxacin was not suitable for brucella hepatitis treatment and also it may cause liver damage. The most appropriate treatment is a standard regimen containing doxycycline.

Full Text

Full text is available in PDF